acquisition of Be-Tabs Pharmaceuticals (Pty) Limited (“Be-Tabs”), in South Africa, for a total consideration of USD 70 Million (500 Million ZAR). The transactions, subject to requisite approvals from South Africa’s Competition Council authority, are expected to be completed in the first quarter of the year 2007.
Friday, December 01, 2006
RANBAXY ACQUIRES SOUTH AFRICAN FIRM
Ranbaxy Laboratories Limited (Ranbaxy), India’s largest pharmaceutical company, today announced the 
acquisition of Be-Tabs Pharmaceuticals (Pty) Limited (“Be-Tabs”), in South Africa, for a total consideration of USD 70 Million (500 Million ZAR). The transactions, subject to requisite approvals from South Africa’s Competition Council authority, are expected to be completed in the first quarter of the year 2007.
acquisition of Be-Tabs Pharmaceuticals (Pty) Limited (“Be-Tabs”), in South Africa, for a total consideration of USD 70 Million (500 Million ZAR). The transactions, subject to requisite approvals from South Africa’s Competition Council authority, are expected to be completed in the first quarter of the year 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment